​

Funding Round

Series B - Arrakis Therapeutics

Series B - Arrakis Therapeutics

Investment Firm

Overview

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

Announced Date

Apr 18, 2019

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

venBio Partners

venBio Partners

venBio Partners is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Nextech Invest

Nextech Invest

Nextech Invest is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

12

Investor Name
Participant InvestorAdvent Life Sciences
Participant InvestorOmega Funds
Participant InvestorGoogle Ventures
Participant InvestorCanaan Partners
Participant InvestorOUP (Osage University Partners)

Round Details and Background

Arrakis Therapeutics raised $75000000 on 2019-04-18 in Series B

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 18, 2019
Series B - Arrakis Therapeutics
13-75.0M
Feb 27, 2017
Series A - Arrakis Therapeutics
6-38.0M

Recent Activity

There is no recent news or activity for this profile.